BAT’s £600 Million Overhaul Hands Accenture a Strategic Role as Shares Languish Near Lows
30.06.2026 - 01:11:12 | boerse-global.de
British American Tobacco has tapped Accenture as the lead partner for its sweeping “Fit2Win” cost-reduction programme, tasking the consultancy with taking over operational functions and rolling out AI-driven efficiencies across the tobacco giant’s global network. The contract will see BAT eliminate roughly 5,500 jobs and shift another 3,500 positions to external partners, with annual savings targeted at £600 million by 2028. Yet the market greeted the news with a shrug — Accenture shares slipped 2.7 percent to €109.80 on the day, just above the 52-week low of €103.60 hit on June 22.
The muted response reflects a deeper malaise. Accenture’s stock has shed more than half its value since the start of the year, now trading more than 56 percent below last July’s all?time high of $259.25. The relative strength index stands at 27.1, firmly in oversold territory. Analysts remain cautious: BNP Paribas trimmed its price target to $130, and DBS downgraded the shares to “Hold,” though some DCF?based models peg fair value at roughly $162, implying a 20 percent discount.
Management, however, is betting that the selloff has gone too far. Accenture boosted its share?repurchase authorisation by $2 billion, bringing the total buyback programme for the current fiscal year to $7.5 billion — a 62 percent increase over the prior year. The repurchases are expected to be completed by the end of August 2026. CEO Julie Sweet made clear the board’s conviction, stating that the current share price does not reflect the company’s underlying financial strength.
Should investors sell immediately? Or is it worth buying Accenture?
The buyback announcement came on the heels of fiscal third?quarter results that presented a mixed picture. Revenue rose 5.6 percent year on year to $18.72 billion, narrowly missing consensus estimates of $18.78 billion. Diluted earnings per share of $3.80 beat the Street’s $3.70 forecast, while free cash flow came in at $3.6 billion. Less encouraging was the 2 percent decline in new bookings to $19.3 billion, and management tempered its full?year revenue growth guidance to between 3 and 4 percent in local currency — a range that would be 4 to 5 percent if not for headwinds in the US federal business. For fiscal 2026, Accenture guided for EPS of $13.78 to $13.90 and maintained a quarterly dividend of $1.63 per share.
Alongside the capital?allocation moves, Accenture unveiled a new business unit on June 23 dubbed “Accenture Edge,” aimed squarely at the mid?market. The division will target companies with annual revenues between $300 million and $3 billion, offering them access to the same AI and technology expertise that the consultancy has honed serving much larger clients. The launch represents a calculated bet on an underserved segment at a time when overall booking momentum has softened.
Institutional investors are split on the stock’s trajectory. Pictet Asset Management slashed its stake by 31.2 percent during the first quarter, offloading around 273,000 shares. By contrast, Janney Montgomery Scott boosted its position by 20.5 percent, and Matrix Asset Advisors increased its holding by a hefty 67.7 percent. The divergence underscores the uncertainty surrounding Accenture’s path back to its 200?day moving average of €190.73 — a gap that will require both strong execution on contracts like the BAT deal and a clear pick?up in new business wins to close.
Ad
Accenture Stock: New Analysis - 30 June
Fresh Accenture information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
